Estimating per-infection cost and burden for dengue and Zika as a function of antibody-dependent enhancement
Table 6
Estimated average costs (in 2024 USD) and burdens (in DALYs) per dengue (D) or Zika (Z) case, or per dengue screening or vaccination series. For each virus, 1 signifies without ADE and 2 with ADE.